Single‐cell digital twins identify drug targets and repurposable medicine in Alzheimer’s disease

Abstract

Background: Alzheimer’s disease (AD) is a complex and poorly understood neurodegenerative disorder with a lack of effective treatments. Novel approaches for identifying FDA‐approved drugs with potential for AD treatment hold promise to address this challenge.

The paper